tiprankstipranks
Trending News
More News >
Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh (AU:DOC)
ASX:DOC
Australian Market

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh (DOC) AI Stock Analysis

Compare
4 Followers

Top Page

AU:DOC

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh

(Sydney:DOC)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 5.2)
Rating:55Neutral
Price Target:
AU$0.16
▲(17.14% Upside)
Action:ReiteratedDate:02/03/26
The score is held back primarily by weak financial fundamentals (continued losses and negative equity/high leverage), partially offset by improving cash flow and solid technical momentum. Valuation remains unattractive due to negative earnings and no dividend support.
Positive Factors
Revenue Growth Trend
Sustained revenue growth over two years indicates expanding customer adoption and stronger top-line scale. For a digital healthcare platform, persistent revenue gains support network effects, improve bargaining power with partners, and provide a foundation for investing in product and clinical capacity over the medium term.
Cash Flow Recovery
Transition to positive operating cash flow and marginally positive free cash flow signals improved cash generation and operational discipline. Durable positive OCF reduces near-term financing needs, lengthens runway, and allows targeted reinvestment in growth or margin-improving initiatives over the next several quarters.
Progress Toward Profitability
Material reduction in losses and improving EBITDA/EBIT indicate the business is narrowing the gap to break-even. This trend reflects cost leverage and revenue mix improvements that, if sustained, support long-term viability and reduce dilution risk from future capital raises.
Negative Factors
Negative Equity & Balance Sheet Weakness
Negative shareholders' equity is a structural red flag that constrains strategic flexibility. It impairs the company's ability to secure credit on favorable terms, heightens insolvency risk in downturns, and limits capacity to fund growth internally, making external financing more likely and costly.
Ongoing Unprofitable Operations
Persistent negative operating margins mean the core service model has not yet proven consistently profitable at scale. Unless margin drivers (pricing, utilization, cost structure) continue to improve, the company will remain dependent on external capital and face pressure to further cut costs or alter its go-to-market strategy.
High Leverage Relative to Assets
Elevated debt against modest assets increases refinancing and interest-rate sensitivity, constraining investment in product and network expansion. High leverage raises covenant and liquidity risk, which can force defensive actions during stress and limit the firm's ability to capitalize on medium-term growth opportunities.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh (DOC) vs. iShares MSCI Australia ETF (EWA)

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Business Overview & Revenue Model

Company DescriptionDoctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland. It offers services in the areas of appointments, patient records, prescriptions, referrals and fit notes, service improvements, and virtual GP consultations in the form of video and phone. The company provides treatments for allergies, bites and stings, cold and flu, headaches and migraines, joint pains, lifestyle support, mental and sexual health, skin conditions, and stomach and digestive problems, as well as offers virtual healthcare, technology platform licensing, and digital design services. It serves medical insurers, employers, retailers, healthcare providers, and direct sales to the public. The company was incorporated in 2013 and is headquartered in London, the United Kingdom.
How the Company Makes MoneyDoctor Care Anywhere generates revenue primarily through its subscription-based model, where patients pay for access to telehealth services and consultations. Key revenue streams include fees from individual consultations, monthly or annual subscriptions for ongoing health services, and partnerships with employers and insurance companies that offer its services as part of employee health benefits. Additionally, the company may earn income from partnerships with healthcare providers and pharmaceutical companies for integrated care solutions and prescription fulfillment services, which contribute to its overall earnings.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Financial Statement Overview

Summary
Revenue and gross profit are improving and cash flow has turned slightly positive, but profitability remains negative and the balance sheet is a major concern due to negative equity and high leverage.
Income Statement
65
Positive
The company has shown a significant improvement in its revenue growth, increasing from $30.42M in 2022 to $39.33M in 2024, marking a growth trend. The Gross Profit has also increased, but the company is still operating at a loss with a Net Income of -$6.29M in 2024, though this is an improvement from -$22.03M in 2022. EBIT and EBITDA have also improved but remain negative, indicating ongoing operational challenges. Overall, the revenue growth and gross profit improvements are positive, but persistent net losses and negative operating margins indicate ongoing profitability challenges.
Balance Sheet
40
Negative
The balance sheet reveals a negative Stockholders' Equity of -$0.65M in 2024, indicating potential financial instability. The Debt-to-Equity ratio is not meaningful due to negative equity, and the company has a high level of debt ($8.27M) relative to its assets ($14.99M), indicating high leverage. The equity ratio is negative, highlighting financial distress. Despite a reduction in debt from 2023, the negative equity position poses a significant risk.
Cash Flow
55
Neutral
Free Cash Flow improved from -$24.38M in 2022 to $0.347M in 2024, indicating improved cash management. The Operating Cash Flow turned positive in 2024 at $0.353M, showing a recovery from previous years' negative cash flows. However, the Free Cash Flow to Net Income ratio remains low, and while operational cash flow has improved, the company's cash position needs further strengthening to ensure sustainability.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue36.76M39.33M38.46M29.31M24.96M11.57M
Gross Profit22.57M22.42M17.69M13.42M10.40M5.69M
EBITDA-1.85M-2.15M-5.78M-16.95M-18.92M-13.38M
Net Income-3.15M-6.29M-10.05M-22.03M-20.22M-31.28M
Balance Sheet
Total Assets15.02M14.99M19.61M22.01M19.69M27.84M
Cash, Cash Equivalents and Short-Term Investments4.79M5.29M8.10M5.41M17.07M21.60M
Total Debt8.46M8.27M11.00M1.59M1.35M1.49M
Total Liabilities15.11M15.64M17.27M9.72M3.86M2.80M
Stockholders Equity-89.00K-645.00K2.33M12.29M15.82M25.04M
Cash Flow
Free Cash Flow2.81M347.00K-8.67M-24.38M-10.10M-7.02M
Operating Cash Flow2.82M353.00K-6.34M-22.03M-8.65M-6.00M
Investing Cash Flow-1.99M-1.65M-2.24M-2.34M-2.42M698.85K
Financing Cash Flow-487.00K-332.00K9.32M5.90M-611.00K46.79M

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.14
Price Trends
50DMA
0.14
Positive
100DMA
0.15
Positive
200DMA
0.14
Positive
Market Momentum
MACD
<0.01
Negative
RSI
55.92
Neutral
STOCH
72.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:DOC, the sentiment is Positive. The current price of 0.14 is below the 20-day moving average (MA) of 0.16, below the 50-day MA of 0.14, and above the 200-day MA of 0.14, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 55.92 is Neutral, neither overbought nor oversold. The STOCH value of 72.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:DOC.

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
55
Neutral
AU$71.50M-10.96-155.10%-6.86%51.88%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
AU$44.36M-8.00-81.30%-36.68%79.41%
45
Neutral
AU$43.89M-4.58-8647.54%25.98%22.10%
43
Neutral
AU$69.45M-11.01
42
Neutral
AU$4.29M-4.77-9.90%34.07%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:DOC
Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh
0.17
0.10
132.88%
AU:GLH
Global Health Limited
0.07
-0.07
-48.97%
AU:SHG
Singular Health Group Ltd
0.28
0.02
5.77%
AU:EMD
Emyria Ltd
0.06
0.02
69.70%
AU:PCK
PainChek Ltd
0.20
-0.15
-42.86%

Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh Corporate Events

Doctor Care Anywhere Posts Strong Cashflow and Rising Patient Engagement in Q4 2025
Jan 28, 2026

Doctor Care Anywhere reported renewed consultation growth in the second half of 2025, with volumes up 3.4% and consistently above 2024 levels since May, supported by a 7.9% year-on-year increase in activated lives to 1.3 million and a rise in repeat patients to 75% of consultations, indicating stronger engagement and loyalty despite seasonal quarter-on-quarter softness. The company delivered its third consecutive quarter of positive cash generation, with £1.1m net operating and investing cash inflow in Q4 and a strengthened cash balance of £6.6m, while advancing digital treatment pilots in musculoskeletal, mental health and dermatology, developing new propositions in corporate weight management and preventative health, and reaffirming medium-term guidance to double revenue over three to five years and target a 15% EBITDA margin, underscoring confidence in its growth trajectory and investment capacity.

The most recent analyst rating on (AU:DOC) stock is a Sell with a A$0.13 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Sets Date for Q4 2025 Activity and Cash Flow Update
Jan 23, 2026

Doctor Care Anywhere Group PLC has announced that it will release its Appendix 4C quarterly cash flow and activity report for the fourth quarter of 2025 on 29 January 2026, providing an update on the company’s recent operational and financial performance. The timing of the release signals continued transparency for investors and other stakeholders as the telehealth provider executes its growth strategy in a competitive digital healthcare market, with the forthcoming report likely to inform assessments of its progress in scaling services and deepening partnerships.

The most recent analyst rating on (AU:DOC) stock is a Sell with a A$0.13 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Director Increases Stake via On-Market Purchase
Jan 14, 2026

Doctor Care Anywhere Group PLC has disclosed that director John Stier increased his direct holding in the company by acquiring 500,000 ordinary fully paid CHESS Depositary Interests on-market, lifting his stake from 3.5 million to 4 million securities at a total cost of AUD 73,183. The trade, placed under a standing instruction during an open trading window and approved by the board, was executed on 8 January 2026 during a closed period due to low market liquidity and holiday-related delays, with the company stating that Stier did not possess any undisclosed price-sensitive information at the time, underscoring compliance with governance and insider trading rules.

The most recent analyst rating on (AU:DOC) stock is a Sell with a A$0.13 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Relocates Headquarters to Mayfair, London
Nov 4, 2025

Doctor Care Anywhere Group PLC has announced a change in its registered office and principal place of business to a new address in Mayfair, London, effective from November 3, 2025. This move signifies a strategic step in the company’s operations, potentially enhancing its industry positioning and operational efficiency, while maintaining all other business details unchanged.

The most recent analyst rating on (AU:DOC) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Doctor Care Anywhere Appoints New Company Secretary
Nov 4, 2025

Doctor Care Anywhere Group PLC has appointed Computershare Entity Solutions (UK) Limited as the new Company Secretary, effective 31 October 2025, following the resignation of Kathy Cong. This change in company secretary is part of the company’s ongoing efforts to enhance its operational framework and ensure robust corporate governance, which may positively impact its strategic growth and stakeholder confidence.

The most recent analyst rating on (AU:DOC) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on Doctor Care Anywhere Group PLC Shs Chess Depository Interests Repr 1 sh stock, see the AU:DOC Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 03, 2026